Hacı Ahmet Aydemir
Research Subjects
Research Interests
Hacı Ahmet Aydemir has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Bayraktar
Atatürk University
2 shared publications - Kamber Kaşali
Atatürk Universitesi
1 shared publication - Mehmet Doğan
Atatürk University
1 shared publication
Latest Publications
- Open Access
- 3 September 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (3) , 145-149
Screening patients with metabolic syndrome for risk of obstructive sleep apnea: the syndrome Z
Aims: Syndrome Z is defined as the coexistence of obstructive sleep apnea (OSA) and metabolic syndrome. As family medicine takes on the role of preventive medicine, syndrome Z is gaining importance in primary care. We aimed to determine the prevalence of syndrome Z in primary care by examining the risk of OSA in individuals with metabolic syndrome. Methods: A cross-sectional study of patients diagnosed with metabolic syndrome according to NCEP-ATP III criteria was conducted at the Family Health Center. Patients' anthropometric measurements (waist circumference, neck circumference, height, and weight) were recorded. OSA risk assessment scales included the Berlin and STOP-BANG questionnaires, which have been shown in studies to be more sensitive tests and were therefore selected for use in our study. Results: Of 156 participants, 37.8% (n=59) were at high risk for OSA on both questionnaires. According to STOP-BANG, 57.4% of men and 31.6% of women were at high risk, which was statistically significant. No association was found between OSA and diabetes, hypertension, and dyslipidemia. However, in both questionnaires, obesity and high body mass index significantly increased the risk of OSA. The area under the curve (AUC) was 0.649 with a specificity of 80.6% using a cut-off of 34.5 kg/m² for BMI. Conclusion: Obese individuals with metabolic syndrome should be assessed for syndrome Z in primary care settings and preventive services should be offered to those at risk.
- 3 September 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (3) , 145-149
Open AccessScreening patients with metabolic syndrome for risk of obstructive sleep apnea: the syndrome Z
Aims: Syndrome Z is defined as the coexistence of obstructive sleep apnea (OSA) and metabolic syndrome. As family medicine takes on the role of preventive medicine, syndrome Z is gaining importance in primary care. We aimed to determine the prevalence of syndrome Z in primary care by examining the risk of OSA in individuals with metabolic syndrome. Methods: A cross-sectional study of patients diagnosed with metabolic syndrome according to NCEP-ATP III criteria was conducted at the Family Health Center. Patients' anthropometric measurements (waist circumference, neck circumference, height, and weight) were recorded. OSA risk assessment scales included the Berlin and STOP-BANG questionnaires, which have been shown in studies to be more sensitive tests and were therefore selected for use in our study. Results: Of 156 participants, 37.8% (n=59) were at high risk for OSA on both questionnaires. According to STOP-BANG, 57.4% of men and 31.6% of women were at high risk, which was statistically significant. No association was found between OSA and diabetes, hypertension, and dyslipidemia. However, in both questionnaires, obesity and high body mass index significantly increased the risk of OSA. The area under the curve (AUC) was 0.649 with a specificity of 80.6% using a cut-off of 34.5 kg/m² for BMI. Conclusion: Obese individuals with metabolic syndrome should be assessed for syndrome Z in primary care settings and preventive services should be offered to those at risk.
- Open Access
- 3 May 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (1) , 11-20
Changes in Smoking Behavior in the COVID-19 Pandemic: A Single Center Study in Family Practice
Objective: There are controversial studies on smoking addiction in the COVID-19 pandemic. While some studies show increased tobacco use during the pandemic, others report increased smoking cessation attempts. This study examined changes in tobacco use and quit intentions during the COVID-19 pandemic compared to pre-pandemic. Methods: A cross-sectional study was designed and three groups were formed by including patients over 18 years of age, who were smokers, and who presented to the Education Family Health Center and had RT-PCR test results for COVID-19. Among these patients, patients with COVID-19 symptoms and complaints and positive RT-PCR test results constituted the COVID-19 positive group, patients who were COVID-19 negative but isolated due to their contacts constituted the contact group, and healthy people without any COVID-19 contact and symptoms constituted the healthy group. Demographic characteristics, smoking status before the COVID-19 pandemic, change in smoking status after COVID-19 test result or contact, and Fagerström nicotine dependence test results were compared. Results: Of the total 131 participants enrolled in the study, 70 were in the healthy group, 31 were in the COVID-19 negative group, and 30 were in the COVID-19 positive group. Men were predominant in three groups (60%, 83.9%, and 73.3% in normal, COVID-19-neg, and COVID-19-positive groups, respectively) with a small significant difference (p=0.048). The mean ages were 41.09±12.85, 38.21±11.69, and 39.47±11.66 years in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, with no significant difference (p>0.05). Fagerström dependence scores were 1.82±1.05, 1.53±0.86, and 1.40±0.72 in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, and were not statistically different (p>0.05). Smoking prevalence decreased by 1.13 (±4.17) cigarettes per day in the healthy group, by 3.97 (±5.31) cigarettes in the COVID negative group, and by 10.14 (±7.86) cigarettes in the COVID positive group, with a statistically significant decrease in smoking prevalence in all three groups (p
- 3 May 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (1) , 11-20
Open AccessChanges in Smoking Behavior in the COVID-19 Pandemic: A Single Center Study in Family Practice
Objective: There are controversial studies on smoking addiction in the COVID-19 pandemic. While some studies show increased tobacco use during the pandemic, others report increased smoking cessation attempts. This study examined changes in tobacco use and quit intentions during the COVID-19 pandemic compared to pre-pandemic. Methods: A cross-sectional study was designed and three groups were formed by including patients over 18 years of age, who were smokers, and who presented to the Education Family Health Center and had RT-PCR test results for COVID-19. Among these patients, patients with COVID-19 symptoms and complaints and positive RT-PCR test results constituted the COVID-19 positive group, patients who were COVID-19 negative but isolated due to their contacts constituted the contact group, and healthy people without any COVID-19 contact and symptoms constituted the healthy group. Demographic characteristics, smoking status before the COVID-19 pandemic, change in smoking status after COVID-19 test result or contact, and Fagerström nicotine dependence test results were compared. Results: Of the total 131 participants enrolled in the study, 70 were in the healthy group, 31 were in the COVID-19 negative group, and 30 were in the COVID-19 positive group. Men were predominant in three groups (60%, 83.9%, and 73.3% in normal, COVID-19-neg, and COVID-19-positive groups, respectively) with a small significant difference (p=0.048). The mean ages were 41.09±12.85, 38.21±11.69, and 39.47±11.66 years in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, with no significant difference (p>0.05). Fagerström dependence scores were 1.82±1.05, 1.53±0.86, and 1.40±0.72 in the healthy, COVID-19 negative, and COVID-19 positive groups, respectively, and were not statistically different (p>0.05). Smoking prevalence decreased by 1.13 (±4.17) cigarettes per day in the healthy group, by 3.97 (±5.31) cigarettes in the COVID negative group, and by 10.14 (±7.86) cigarettes in the COVID positive group, with a statistically significant decrease in smoking prevalence in all three groups (p
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (2)
Aile Hekimliğinde Toplum Odaklılık Temel Yetkinliği Perspektifinden: Aynı Ailede İki Gilbert Sendromu Vakası
- 1 January 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (2)
Aile Hekimliğinde Toplum Odaklılık Temel Yetkinliği Perspektifinden: Aynı Ailede İki Gilbert Sendromu Vakası
- Open Access
- 26 December 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (3) , 553-556
Aile Hekimliğinde Konuşma Bozukluğu Şikayeti: Nadir Bir Olgu Dilde Hemanjiom
Hemangiomas are the most common benign tumors of the head and neck region, but are rarely seen in the oral cavity. Tongue localized hemangiomas are encountered in 7.8% of cases. Depending on their size, hemangiomas located on the tongue can cause recurrent spontaneous bleeding, pain, speech and chewing disorders and shortness of breath. In this article, a case of hemangioma of the tongue characterized by speech disorder in a 7-year-old boy who presented to our family medicine outpatient clinic is presented and discussed in the light of the literature.
- 26 December 2023
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 25 (3) , 553-556
Open AccessAile Hekimliğinde Konuşma Bozukluğu Şikayeti: Nadir Bir Olgu Dilde Hemanjiom
Hemangiomas are the most common benign tumors of the head and neck region, but are rarely seen in the oral cavity. Tongue localized hemangiomas are encountered in 7.8% of cases. Depending on their size, hemangiomas located on the tongue can cause recurrent spontaneous bleeding, pain, speech and chewing disorders and shortness of breath. In this article, a case of hemangioma of the tongue characterized by speech disorder in a 7-year-old boy who presented to our family medicine outpatient clinic is presented and discussed in the light of the literature.
- Open Access
- 15 December 2023
- Published by University of Health Science in Bütünleyici ve Anadolu Tıbbı Dergisi
- Vol. 4 (4) , 34-44
Proloterapinin Sekonder ve İyatrojenik Etkileri
Proloterapi, biyolojik maddelerin enjekte edilerek lokal inflamatuar iyileşme sürecini başlatmayı hedefleyen rejeneratif bir tedavi uygulamasıdır. Son zamanlarda birçok hastalığın tedavisine yönelik yaygın kullanım alanı bulan proloterapi uygulamasına bağlı gözlemlenen bazı yan etkiler literatürde sunulmuştur. Bu derlememizde proloterapi uygulaması ile ilişkili uygulamada dikkat edilmesi gereken hususlar, yan etkiler ve kontrendikasyon durumları genel olarak incelenmiştir. Genel olarak proloterapi, yan etki profili ve kontrendikasyonlar açısından diğer enjeksiyon yöntemleri ile benzerlik göstermekte, ancak, uygulamayı yapan kişinin tecrübesi ve uygulamada rehber bir görüntüleme yöntemi kullanılmasının yan etkilerin azalmasına yardımcı olacağı öngörülmektedir
- 15 December 2023
- Published by University of Health Science in Bütünleyici ve Anadolu Tıbbı Dergisi
- Vol. 4 (4) , 34-44
Open AccessProloterapinin Sekonder ve İyatrojenik Etkileri
Proloterapi, biyolojik maddelerin enjekte edilerek lokal inflamatuar iyileşme sürecini başlatmayı hedefleyen rejeneratif bir tedavi uygulamasıdır. Son zamanlarda birçok hastalığın tedavisine yönelik yaygın kullanım alanı bulan proloterapi uygulamasına bağlı gözlemlenen bazı yan etkiler literatürde sunulmuştur. Bu derlememizde proloterapi uygulaması ile ilişkili uygulamada dikkat edilmesi gereken hususlar, yan etkiler ve kontrendikasyon durumları genel olarak incelenmiştir. Genel olarak proloterapi, yan etki profili ve kontrendikasyonlar açısından diğer enjeksiyon yöntemleri ile benzerlik göstermekte, ancak, uygulamayı yapan kişinin tecrübesi ve uygulamada rehber bir görüntüleme yöntemi kullanılmasının yan etkilerin azalmasına yardımcı olacağı öngörülmektedir